This Study Will Evaluate the Safety, Tolerability, and Efficacy of ANB032 in Subjects with Moderate to Severe Atopic Dermatitis (AD).
Public ClinicalTrials.gov record NCT05935085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of ANB032 in the Treatment of Subjects with Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the safety, tolerability, and efficacy of ANB032 in subjects with moderate to severe atopic dermatitis (AD).
Study identification
- NCT ID
- NCT05935085
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 201 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 13, 2023 (Actual)
- Primary completion
- Oct 16, 2024 (Actual)
- Completion
- Jan 7, 2025 (Actual)
- Last update posted
- Feb 14, 2025
2023 – 2025
United States locations
- U.S. sites
- 41
- U.S. states
- 18
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| AnaptysBio Investigative Site 10-140 | Anaheim | California | 92801 | — |
| AnaptysBio Investigative Site 10-141 | Cerritos | California | 90703 | — |
| AnaptysBio Investigative Site 10-121 | Fountain Valley | California | 92708 | — |
| AnaptysBio Investigative Site 10-107 | Fremont | California | 94538 | — |
| AnaptysBio Investigative Site 10-120 | Lancaster | California | 93534 | — |
| AnaptysBio Investigative 10-125 | Lomita | California | 90717 | — |
| AnaptysBio Investigative Site 10-146 | Oxnard | California | 93030 | — |
| AnaptysBio Investigative Site 10-147 | Pasadena | California | 91101 | — |
| AnaptysBio Investigative Site 10-112 | Santa Monica | California | 90404 | — |
| AnaptysBio Investigative Site 10-136 | Doral | Florida | 33122 | — |
| AnaptysBio Investigative Site 10-133 | Miami | Florida | 33125 | — |
| AnaptysBio Investigative Site 10-116 | Miami | Florida | 33126 | — |
| AnaptysBio Investigative Site 10-134 | Miami | Florida | 33174 | — |
| AnaptysBio Investigative Site 10-106 | Miami | Florida | 33179 | — |
| AnaptysBio Investigative Site 10-122 | Atlanta | Georgia | 30328 | — |
| AnaptysBio Investigative Site 10-130 | Boise | Idaho | 83702 | — |
| AnaptysBio Investigative Site 10-151 | Flossmoor | Illinois | 60422 | — |
| AnaptysBio Investigative Site 10-127 | Clarksville | Indiana | 47129 | — |
| AnaptysBio Investigative Site 10-149 | Merrillville | Indiana | 46410 | — |
| AnaptysBio Investigative Site 10-128 | New Albany | Indiana | 47150 | — |
| AnaptysBio Investigative Site 10-137 | Baton Rouge | Louisiana | 70808 | — |
| AnaptysBio Investigative Site 10-131 | Methuen | Massachusetts | 01844 | — |
| AnaptysBio Investigative Site 10-126 | Ann Arbor | Michigan | 48109 | — |
| AnaptysBio Investigative Site 10-139 | Auburn Hills | Michigan | 48326 | — |
| AnaptysBio Investigative Site 10-114 | Detroit | Michigan | 48202 | — |
| AnaptysBio Investigative Site 10-138 | Troy | Michigan | 48084 | — |
| AnaptysBio Investigative Site 10-150 | Hazelwood | Missouri | 63042 | — |
| AnaptysBio Investigative Site 10-110 | Saint Joseph | Missouri | 64506 | — |
| AnaptysBio Investigative Site 10-148 | Las Vegas | Nevada | 89121 | — |
| AnaptysBio Investigative Site 10-109 | Charlotte | North Carolina | 28277 | — |
| AnaptysBio Investigative Site 10-108 | Wilmington | North Carolina | 28205 | — |
| AnaptysBio Investigative Site 10-129 | Mason | Ohio | 45040 | — |
| AnaptysBio Investigative Site 10-113 | Portland | Oregon | 97223 | — |
| AnaptysBio Investigative Site 10-145 | Philadelphia | Pennsylvania | 19144 | — |
| AnaptysBio Investigative Site 10-119 | Nashville | Tennessee | 37215 | — |
| AnaptysBio Investigative Site 10-144 | Baytown | Texas | 77521 | — |
| AnaptysBio Investigative Site 10-124 | Dallas | Texas | 75235 | — |
| AnaptysBio Investigative Site 10-105 | Frisco | Texas | 75034 | — |
| AnaptysBio Investigative Site 10-142 | Katy | Texas | 77494 | — |
| AnaptysBio Investigative Site 10-104 | San Antonio | Texas | 78213 | — |
| AnaptysBio Investigative Site 10-132 | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 37 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05935085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 14, 2025 · Synced Oct 16, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05935085 live on ClinicalTrials.gov.